Tapewire

Nasdaq · USD

TARA

Protara Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6203
SEC CIK
0001359931
Parsed reports
309

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202602
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2026 Filed Jul 1, 2026 20:10 UTC
Shefferman JesseDirector · CEO and President
GiftCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 6

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 691,832

Read SEC document
June 30, 2026 Filed Jul 1, 2026 20:10 UTC
Shefferman JesseDirector · CEO and President
GiftCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 5

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 696,832

Read SEC document
June 30, 2026 Filed Jul 1, 2026 20:10 UTC
Shefferman JesseDirector · CEO and President
GiftCommon Stock 7,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 4

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700,832

Read SEC document
June 30, 2026 Filed Jul 1, 2026 20:10 UTC
Shefferman JesseDirector · CEO and President
GiftCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 3

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 707,832

Read SEC document
June 29, 2026 Filed Jul 1, 2026 20:10 UTC
Shefferman JesseDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 215,687 $0.00 Strike: $1.91 $0.00
Disclosure

SEC source: 0001213900-26-074238 · marketforms-73501.xml · derivative · entry 8

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,313

Underlying: Common Stock · 215,687 shares

Expires 2034-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares underlying the option vested on January 19, 2025 and the remaining shares have vested or will vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 20:10 UTC
Shefferman JesseDirector · CEO and President
SaleCommon Stock 215,687 $4.09 $882,159.83
Disclosure

SEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 2

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 721,832

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.03 to $4.14, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 20:10 UTC
Shefferman JesseDirector · CEO and President
Exercise / conversionCommon Stock 215,687 $1.91 $411,962.17
Disclosure

SEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 1

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 937,519

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:05 UTC GrantStock Option (Right to Buy) · Derivative 31,000 $0.00 Strike: $3.94 $0.00
Disclosure

SEC source: 0001213900-26-069249 · marketforms-73186.xml · derivative · entry 1

Solomon Michael Edward · CIK 0001799320 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common Stock · 31,000 shares

Expires 2036-06-14

F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:05 UTC
Huang JaneDirector
GrantStock Option (Right to Buy) · Derivative 31,000 $0.00 Strike: $3.94 $0.00
Disclosure

SEC source: 0001213900-26-069246 · marketforms-73183.xml · derivative · entry 1

Huang Jane · CIK 0001683913 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common Stock · 31,000 shares

Expires 2036-06-14

F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:05 UTC GrantStock Option (Right to Buy) · Derivative 31,000 $0.00 Strike: $3.94 $0.00
Disclosure

SEC source: 0001213900-26-069250 · marketforms-73187.xml · derivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common Stock · 31,000 shares

Expires 2036-06-14

F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:05 UTC GrantStock Option (Right to Buy) · Derivative 31,000 $0.00 Strike: $3.94 $0.00
Disclosure

SEC source: 0001213900-26-069245 · marketforms-73182.xml · derivative · entry 1

GARCEAU ROGER · CIK 0001451767 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common Stock · 31,000 shares

Expires 2036-06-14

F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:05 UTC GrantStock Option (Right to Buy) · Derivative 31,000 $0.00 Strike: $3.94 $0.00
Disclosure

SEC source: 0001213900-26-069247 · marketforms-73184.xml · derivative · entry 1

SARGEN GREGORY · CIK 0001227835 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common Stock · 31,000 shares

Expires 2036-06-14

F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:05 UTC GrantStock Option (Right to Buy) · Derivative 31,000 $0.00 Strike: $3.94 $0.00
Disclosure

SEC source: 0001213900-26-069243 · marketforms-73180.xml · derivative · entry 1

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common Stock · 31,000 shares

Expires 2036-06-14

F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:05 UTC GrantStock Option (Right to Buy) · Derivative 31,000 $0.00 Strike: $3.94 $0.00
Disclosure

SEC source: 0001213900-26-069248 · marketforms-73185.xml · derivative · entry 1

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common Stock · 31,000 shares

Expires 2036-06-14

F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:05 UTC GrantStock Option (Right to Buy) · Derivative 31,000 $0.00 Strike: $3.94 $0.00
Disclosure

SEC source: 0001213900-26-069244 · marketforms-73181.xml · derivative · entry 1

Flannelly Barry P · CIK 0001615842 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common Stock · 31,000 shares

Expires 2036-06-14

F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 02, 2026 Filed Jun 3, 2026 20:55 UTC
CONKLING WILLIAMChief Commercial Officer
Tax withholdingCommon Stock 6,008 $4.34 $26,074.72
Disclosure

SEC source: 0001213900-26-064792 · marketforms-73188.xml · nonDerivative · entry 1

CONKLING WILLIAM · CIK 0001852018 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,992

F1 · shares: 1. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on June 2, 2025.

Read SEC document
April 08, 2026 Filed Apr 9, 2026 21:25 UTC
Zummo JacquelineChief R&D Officer
SaleCommon Stock 1,134 $5.40 $6,123.60
Disclosure

SEC source: 0001213900-26-042079 · marketforms-72911.xml · nonDerivative · entry 1

Zummo Jacqueline · CIK 0001798929 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,827

F1 · shares: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:05 UTC
Zummo JacquelineChief R&D Officer
SaleCommon Stock 22,598 $5.26 $118,865.48
Disclosure

SEC source: 0001213900-26-039328 · marketforms-72854.xml · nonDerivative · entry 1

Zummo Jacqueline · CIK 0001798929 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,961

F1 · shares: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.31, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 21:10 UTC
Zummo JacquelineChf Scientific Operations Off
Tax withholdingCommon Stock 3,724 $6.67 $24,839.08
Disclosure

SEC source: 0001213900-26-008223 · marketforms-71933.xml · nonDerivative · entry 1

Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,559

F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 21:10 UTC
Fabbio PatrickChief Financial Officer
Tax withholdingCommon Stock 3,261 $6.67 $21,750.87
Disclosure

SEC source: 0001213900-26-008221 · marketforms-71931.xml · nonDerivative · entry 1

Fabbio Patrick · CIK 0001658859 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,115

F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 21:10 UTC
Fry HannahVP, Controller
Tax withholdingCommon Stock 1,457 $6.67 $9,718.19
Disclosure

SEC source: 0001213900-26-008222 · marketforms-71932.xml · nonDerivative · entry 1

Fry Hannah · CIK 0001938146 · VP, Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,723

F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025.

Read SEC document
January 26, 2026 Filed Jan 27, 2026 21:10 UTC
Shefferman JesseDirector · CEO and President
Tax withholdingCommon Stock 8,732 $6.67 $58,242.44
Disclosure

SEC source: 0001213900-26-008224 · marketforms-71934.xml · nonDerivative · entry 1

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,021,832

F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 21:30 UTC
Zummo JacquelineChf Scientific Operations Off
Tax withholdingCommon Stock 6,578 $5.60 $36,836.80
Disclosure

SEC source: 0001213900-26-006708 · marketforms-71770.xml · nonDerivative · entry 1

Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,283

F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 21:30 UTC
Fabbio PatrickChief Financial Officer
Tax withholdingCommon Stock 3,063 $5.60 $17,152.80
Disclosure

SEC source: 0001213900-26-006709 · marketforms-71771.xml · nonDerivative · entry 1

Fabbio Patrick · CIK 0001658859 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,376

F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2024.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 21:30 UTC
Fry HannahVP, Controller
Tax withholdingCommon Stock 2,132 $5.60 $11,939.20
Disclosure

SEC source: 0001213900-26-006707 · marketforms-71769.xml · nonDerivative · entry 1

Fry Hannah · CIK 0001938146 · VP, Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,180

F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024.

Read SEC document
January 20, 2026 Filed Jan 22, 2026 21:30 UTC
Shefferman JesseDirector · CEO and President
Tax withholdingCommon Stock 16,322 $5.60 $91,403.20
Disclosure

SEC source: 0001213900-26-006711 · marketforms-71772.xml · nonDerivative · entry 1

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,030,564

F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:37 UTC
CONKLING WILLIAMChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 158,000 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001213900-26-006231 · marketforms-71898.xml · derivative · entry 2

CONKLING WILLIAM · CIK 0001852018 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,000

Underlying: Common Stock · 158,000 shares

Expires 2036-01-15

F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:37 UTC
CONKLING WILLIAMChief Commercial Officer
GrantCommon Stock 26,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-006231 · marketforms-71898.xml · nonDerivative · entry 1

CONKLING WILLIAM · CIK 0001852018 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,000

F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:36 UTC
Zummo JacquelineChf Scientific Operations Off
GrantStock Option (Right to Buy) · Derivative 180,000 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001213900-26-006225 · marketforms-71895.xml · derivative · entry 2

Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires 2036-01-15

F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:36 UTC
Zummo JacquelineChf Scientific Operations Off
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-006225 · marketforms-71895.xml · nonDerivative · entry 1

Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,861

F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:37 UTC
Fabbio PatrickChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001213900-26-006230 · marketforms-71896.xml · derivative · entry 2

Fabbio Patrick · CIK 0001658859 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2036-01-15

F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:37 UTC
Fabbio PatrickChief Financial Officer
GrantCommon Stock 28,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-006230 · marketforms-71896.xml · nonDerivative · entry 1

Fabbio Patrick · CIK 0001658859 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,439

F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:36 UTC
Fry HannahVP, Controller
GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001213900-26-006229 · marketforms-71897.xml · derivative · entry 2

Fry Hannah · CIK 0001938146 · VP, Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2036-01-15

F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:36 UTC
Fry HannahVP, Controller
GrantCommon Stock 9,500 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-006229 · marketforms-71897.xml · nonDerivative · entry 1

Fry Hannah · CIK 0001938146 · VP, Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,312

F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:36 UTC
Nicacio Leonardo VianaChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 158,000 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001213900-26-006228 · marketforms-71899.xml · derivative · entry 2

Nicacio Leonardo Viana · CIK 0002064901 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,000

Underlying: Common Stock · 158,000 shares

Expires 2036-01-15

F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:36 UTC
Nicacio Leonardo VianaChief Medical Officer
GrantCommon Stock 26,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-006228 · marketforms-71899.xml · nonDerivative · entry 1

Nicacio Leonardo Viana · CIK 0002064901 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,181

F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:36 UTC
Shefferman JesseDirector · CEO and President
GrantStock Option (Right to Buy) · Derivative 524,000 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001213900-26-006226 · marketforms-71894.xml · derivative · entry 2

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 524,000

Underlying: Common Stock · 524,000 shares

Expires 2036-01-15

F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 21:36 UTC
Shefferman JesseDirector · CEO and President
GrantCommon Stock 87,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-006226 · marketforms-71894.xml · nonDerivative · entry 1

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,046,886

F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Read SEC document
June 27, 2025 Filed Jun 30, 2025 20:10 UTC
Shefferman JesseDirector · CEO and President
GiftCommon Stock 3,367 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-059655 · marketforms-69999.xml · nonDerivative · entry 4

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 959,886

Read SEC document
June 27, 2025 Filed Jun 30, 2025 20:10 UTC
Shefferman JesseDirector · CEO and President
GiftCommon Stock 10,200 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-059655 · marketforms-69999.xml · nonDerivative · entry 3

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 963,253

Read SEC document
June 26, 2025 Filed Jun 30, 2025 20:10 UTC
Shefferman JesseDirector · CEO and President
GiftCommon Stock 3,400 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-059655 · marketforms-69999.xml · nonDerivative · entry 2

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 973,453

Read SEC document
June 26, 2025 Filed Jun 30, 2025 20:10 UTC
Shefferman JesseDirector · CEO and President
GiftCommon Stock 1,700 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-059655 · marketforms-69999.xml · nonDerivative · entry 1

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 976,853

Read SEC document
June 24, 2025 Filed Jul 7, 2025 20:10 UTC
Shefferman JesseDirector · CEO and President
GiftCommon Stock 300,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-061772 · marketforms-70060.xml · nonDerivative · entry 1

Shefferman Jesse · CIK 0001799167 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 659,886

F1 · ownership.direct: On June 24, 2025, the reporting person transferred 300,000 shares of common stock to The Samhold Family Trust for no consideration. Members of the reporting person's immediate family are the sole beneficiaries of the trust and a member of the reporting person's immediate family serves as a trustee thereof. The reporting person remains the beneficial owner of the securities held by the trust.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:05 UTC GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $3.26 $0.00
Disclosure

SEC source: 0001213900-25-054288 · marketforms-69818.xml · derivative · entry 1

Solomon Michael Edward · CIK 0001799320 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:05 UTC
Huang JaneDirector
GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $3.26 $0.00
Disclosure

SEC source: 0001213900-25-054284 · marketforms-69814.xml · derivative · entry 1

Huang Jane · CIK 0001683913 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:05 UTC GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $3.26 $0.00
Disclosure

SEC source: 0001213900-25-054285 · marketforms-69815.xml · derivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:05 UTC GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $3.26 $0.00
Disclosure

SEC source: 0001213900-25-054283 · marketforms-69813.xml · derivative · entry 1

GARCEAU ROGER · CIK 0001451767 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:05 UTC GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $3.26 $0.00
Disclosure

SEC source: 0001213900-25-054286 · marketforms-69816.xml · derivative · entry 1

SARGEN GREGORY · CIK 0001227835 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:05 UTC GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $3.26 $0.00
Disclosure

SEC source: 0001213900-25-054280 · marketforms-69807.xml · derivative · entry 1

BESHAR LUKE M · CIK 0001192128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:05 UTC GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $3.26 $0.00
Disclosure

SEC source: 0001213900-25-054287 · marketforms-69817.xml · derivative · entry 1

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.